PneumoADIP
Encyclopedia
Pneumococcal vaccines Accelerated Development and Introduction Plan (PnemoADIP) is a small, dedicated team based at Johns Hopkins Bloomberg School of Public Health
and is supported by a $30 million grant from the Global Alliance for Vaccines and Immunization
. Its mission is to improve child survival and health by accelerating the evaluation of and access to new, lifesaving pneumococcal vaccines for the world's children.
PneumoADIP aims to achieve its goals through partnerships with countries, donors, academia, international organizations, and industry. PneumoADIP coordinates its activities through a strategic alliance with the World Health Organization
.
PneumoADIP's Executive Director is Orin Levine
.
In April 2009, Rwanda became the first low-income country to introduce the pneumococcal vaccine Prevnar into its routine schedule for children. This introduction is expected to save thousands of lives each year and dramatically decrease the economic burden of this disease. This introduction marked a major milestone for PneumoADIP and for global health. Historically it has taken 15–25 years for new vaccines to reach children in low-income countries. Rwanda has introduced the vaccine only 9 years after it was initially licensed in the U.S. and only three years after universal introduction began in France, Germany, and the United Kingdom.
PnemoADIP's Director of Alliances and Information is Lois Privor-Dumm
.
PneumoADIP is a member of the Global Coalition Against Pneumonia
and supports World Pneumonia Day
on November 2, 2009.
Johns Hopkins Bloomberg School of Public Health
The Johns Hopkins Bloomberg School of Public Health is part of Johns Hopkins University in Baltimore, Maryland, United States...
and is supported by a $30 million grant from the Global Alliance for Vaccines and Immunization
Global Alliance for Vaccines and Immunization
The GAVI Alliance is a public-private global health partnership committed to saving children’s lives and protecting people’s health by increasing access to immunisation in poor countries...
. Its mission is to improve child survival and health by accelerating the evaluation of and access to new, lifesaving pneumococcal vaccines for the world's children.
PneumoADIP aims to achieve its goals through partnerships with countries, donors, academia, international organizations, and industry. PneumoADIP coordinates its activities through a strategic alliance with the World Health Organization
World Health Organization
The World Health Organization is a specialized agency of the United Nations that acts as a coordinating authority on international public health. Established on 7 April 1948, with headquarters in Geneva, Switzerland, the agency inherited the mandate and resources of its predecessor, the Health...
.
PneumoADIP's Executive Director is Orin Levine
Orin Levine
Dr. Orin Levine is a recognized expert in the fields international public health, child survival, and pneumonia. He currently acts as the Executive Director of the , the Co-Chair of the Pneumococcal Awareness Council of Experts , and is an Associate Professor at The Johns Hopkins Bloomberg School...
.
In April 2009, Rwanda became the first low-income country to introduce the pneumococcal vaccine Prevnar into its routine schedule for children. This introduction is expected to save thousands of lives each year and dramatically decrease the economic burden of this disease. This introduction marked a major milestone for PneumoADIP and for global health. Historically it has taken 15–25 years for new vaccines to reach children in low-income countries. Rwanda has introduced the vaccine only 9 years after it was initially licensed in the U.S. and only three years after universal introduction began in France, Germany, and the United Kingdom.
PnemoADIP's Director of Alliances and Information is Lois Privor-Dumm
Lois Privor-Dumm
Lois Privor-Dumm is a respected expert in the field of vaccine introduction. She is especially recognized for her work with new vaccine introduction, which has included strategies to accelerate access in low and middle income countries, policy research, advocacy, communications and large country...
.
PneumoADIP is a member of the Global Coalition Against Pneumonia
Global Coalition Against Pneumonia
The Global Coalition Against Child Pneumonia exists to raise global awareness about the deadly toll of the number 1 killer of children - pneumonia. Every year 155 million children under 5 get sick and 1.6 million lose their lives to pneumonia, more than all child deaths combined from AIDS, malaria...
and supports World Pneumonia Day
World Pneumonia Day
World Pneumonia Day provides an annual forum for the world to stand together and demand action in the fight against pneumonia. More than 100 organizations representing the interests of children joined forces as the Global Coalition against Child Pneumonia to hold the first World Pneumonia Day on...
on November 2, 2009.
External links
- PneumoADIP - Pneumococcal vaccines Accelerated Development and Introduction Plan
- Bill and Melinda Gates Foundation
- GAVI Alliance
- The Hib Initiative
- November 2nd is World Pneumonia Day
- Baltimore Sun Article The Right Fight
- Rwanda: President Meets Pneumococcal Vaccine Sponsors